Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Fair Development in China / / edited by Qingyun Jiang, Lixian Qian, Min Ding
| Fair Development in China / / edited by Qingyun Jiang, Lixian Qian, Min Ding |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (VIII, 284 p. 9 illus., 5 illus. in color.) |
| Disciplina | 330.951 |
| Collana | Perspectives on Sustainable Growth |
| Soggetto topico |
Globalization
Markets Management Industrial management Social policy Economic growth Sustainable development Emerging Markets/Globalization Innovation/Technology Management Social Policy Economic Growth Sustainable Development |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I Overview -- Ch 1 From Equality to Fairness -- Ch 2 Four-wheel Driven Governance -- Section II Individual Perspective -- Ch 3 Fair Values and Social Psychology Construction -- Ch 4 Family Life Style and Individual Circle -- Ch 5 Civil Needs and Fair Development -- Ch 6 Co-creating Ecological Values, Green Index for Individuals and Families -- Section III Organizational Perspective -- Ch 7 Corporate Social Responsibility -- Ch 8 Fairness-oriented Green Marketing -- Ch 9 Social Enterprises -- Ch 10 Interaction between Firms and Consumers -- Ch 11 Fairness Governance and Action in Inter-firm Organizations -- Section IV Government Perspective -- Ch 12 Governance and Transparency -- Ch 13 Balance Equity and Efficiency in Economic and Social Plan -- Ch 14 Public Investment -- Ch 15 Move from Manufacturing to Services, from Materialism to Virtual Consumption -- Section V Social Perspective -- Ch 16 Social Structure and Interactivities of Social Classes -- Ch 17 Fairness and Social Evolution -- Ch 18 Virtual Social Network -- Ch 19 Social Welfare -- Section VI Internationalization of Fair Development -- Ch 20 International Influences on Fair Development in China -- Ch 21 Fairness of Chinese Firms in Global Market -- Ch 22 Fairness of MNCs in China -- Section VII Conclusion -- Ch 23 Measure Fair development -- Ch 24 Balance Current and Future Social Development in Multi-Dimensions -- Ch 25 Fair Development Framework for Actions. |
| Record Nr. | UNINA-9910254923403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Innovation and Marketing in the Pharmaceutical Industry : Emerging Practices, Research, and Policies / / edited by Min Ding, Jehoshua Eliashberg, Stefan Stremersch
| Innovation and Marketing in the Pharmaceutical Industry : Emerging Practices, Research, and Policies / / edited by Min Ding, Jehoshua Eliashberg, Stefan Stremersch |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Springer, , 2014 |
| Descrizione fisica | 1 online resource (763 p.) |
| Disciplina | 615.1068 |
| Collana | International Series in Quantitative Marketing |
| Soggetto topico |
Pharmaceutical technology
Economic policy Finance Pharmaceutical Sciences/Technology R & D/Technology Policy Finance, general |
| ISBN | 1-4614-7801-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1 The Pharmaceutical Industry: Specificity, Challenges and What You Can Learn from this Book -- Chapter 2 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development -- Chapter 3 Portfolio Management in New Drug Development -- Chapter 4 Grassroots Innovation: A Promising Innovation Paradigm for Pharmaceutical Companies -- Chapter 5 New Challenges in Alliance Portfolio Management -- Chapter 6 Evaluating the Impact of Treatment Effectiveness and Side Effects in Prescribing Choices -- Chapter 7 The Successful Launch and Diffusion of New Therapies -- Chapter 8 Pharmaceutical Lifecycle Extension Strategies -- Chapter 9 Patent Expiry and Pharmaceutical Market Opportunities at the Nexus of Pricing and Innovation Policy -- Chapter 10 Risk Assessment: The Consumer as an Intuitive Statistician -- Chapter 11 Efficacy Expectations and Adherence: Evidence of Consumer Biases and Heuristics in Pharmaceutical Marketing -- Chapter 12 Factors Affecting Adherence to Governmental Health Warnings and the Case of Over-the-Counter Cough and Cold Medications (OTC-CCM) in Children Under Two -- Chapter 13 Vaccine Marketing -- Chapter 14 Patient Empowerment: Consequences for Pharmaceutical Marketing and for the Patient-Physician Relationship -- Chapter 15 Leveraging Peer-to-Peer Networks in Pharmaceutical Marketing -- Chapter 16 Leveraging Social Media in the Pharmaceutical Industry -- Chapter 17 Understanding Sample Usage and Sampling as a Promotion Tool: State of Industry Practice and Current Research -- Chapter 18 Pharmaceutical Detailing Elasticities: A Meta-Analysis -- Chapter 19 Marketing Spending Models -- Chapter 20 Modeling the Effects of Promotional Efforts on Pharmaceutical Demand: What We Know and Challenges for the Future -- Chapter 21 Direct-to-Consumer Advertising of Pharmaceuticals: An Integrative Review -- Chapter 22 How DTCA Influences Prescription Pharmaceutical Markets -- Chapter 23 Spillovers and Other Externalities in Pharmaceutical Marketing -- Chapter 24 Closing the Marketing Strategy-Tactics Gap: An Institutional Theory Analysis of Pharmaceutical Value Chain. |
| Record Nr. | UNINA-9910298322503321 |
| New York, NY : , : Springer New York : , : Imprint : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||